Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SH-BC-893
Cat. No.:
OB0425LY-088
Appearance:
Liquid
Purity:
99.34%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
SH-BC-893 is a high-quality anti-neoplastic sphingolipid analog.
Synonyms:
1841409-92-4; ((2S,3R)-3-(4-Octylphenyl)pyrrolidin-2-yl)methanol hydrochloride; [(2S,3R)-3-(4-Octylphenyl)pyrrolidin-2-yl]methanol, hydrochloride
CAS No.:
1841409-92-4
Compound CID:
155512882
Formula:
C19H32ClNO
Formula Weight:
325.92
Specification
Target:
Mitochondrial metabolism
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
SH-BC-893 can be used for mitochondrial dysfunction, obesity and cancer research.
